IRIS
FIORINO, GIONATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.360
EU - Europa 916
AS - Asia 672
SA - Sud America 270
AF - Africa 15
OC - Oceania 1
Totale 3.234
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.342
SE - Svezia 316
SG - Singapore 297
BR - Brasile 246
IE - Irlanda 234
CN - Cina 214
DE - Germania 96
HK - Hong Kong 95
UA - Ucraina 59
GB - Regno Unito 56
FI - Finlandia 37
FR - Francia 34
RU - Federazione Russa 33
VN - Vietnam 30
IT - Italia 29
AR - Argentina 9
CA - Canada 9
MX - Messico 7
BE - Belgio 5
IQ - Iraq 5
VE - Venezuela 5
ZA - Sudafrica 5
BD - Bangladesh 4
EC - Ecuador 4
ID - Indonesia 4
CH - Svizzera 3
JP - Giappone 3
MA - Marocco 3
TN - Tunisia 3
TR - Turchia 3
AM - Armenia 2
CO - Colombia 2
EG - Egitto 2
IN - India 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NL - Olanda 2
NP - Nepal 2
PE - Perù 2
PK - Pakistan 2
PL - Polonia 2
AG - Antigua e Barbuda 1
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PY - Paraguay 1
RO - Romania 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.234
Salva come PNG Salva come JPEG
Città #
Chandler 280
Dublin 234
Singapore 159
Dallas 150
Ashburn 135
Nyköping 133
Jacksonville 128
Beijing 106
Hong Kong 95
Dearborn 45
Lancaster 39
Princeton 38
Medford 36
Cambridge 35
Los Angeles 33
Des Moines 31
The Dalles 31
Boardman 27
Munich 25
Turku 19
São Paulo 18
Ann Arbor 17
Buffalo 16
Belo Horizonte 15
Jinan 13
Moscow 13
Shenyang 13
Tianjin 13
Ho Chi Minh City 11
Redondo Beach 10
Rio de Janeiro 10
San Mateo 9
Brooklyn 7
Helsinki 7
New York 7
Curitiba 6
Düsseldorf 6
Pozzuolo Martesana 6
Wilmington 6
Zhengzhou 6
Brasília 5
Brussels 5
Hanoi 5
Hebei 5
Lauterbourg 5
Porto Alegre 5
Santo André 5
Washington 5
Bremen 4
London 4
Messina 4
Santa Clara 4
Taizhou 4
Woodbridge 4
Atlanta 3
Biên Hòa 3
Boston 3
Campinas 3
Canoas 3
Caracas 3
Fuzhou 3
Guangzhou 3
Guarulhos 3
Hangzhou 3
Houston 3
Itajubá 3
Johannesburg 3
João Pessoa 3
Lanzhou 3
Maceió 3
Nanchang 3
Rome 3
Stockholm 3
Vancouver 3
Aparecida de Goiânia 2
Aracaju 2
Baghdad 2
Barra Mansa 2
Cairo 2
Carapicuíba 2
Caxias do Sul 2
Changsha 2
Chicago 2
Dhaka 2
Espumoso 2
Feira de Santana 2
Frankfurt am Main 2
Guaratuba 2
Guayaquil 2
Haikou 2
Haiphong 2
Itatiba 2
Lima 2
Marília 2
Mexico City 2
Milan 2
Montreal 2
Nanjing 2
Newark 2
Niterói 2
Totale 2.164
Salva come PNG Salva come JPEG
Nome #
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. 116
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 106
Response evaluation and safety of thiopurines in the treatment of inflammatory bowel diseases (IBD): safety and response evaluation. 104
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 104
H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biologics. 101
Balanced Propofol Sedation (BPS) Administered by Non-Anesthesiologists vs Midazolam Alone for Endoscopic Procedure in Patients With IBD: A Single Center Open-Label Trial 100
Different Segmental Transit Time (TT) Through the Small Bowel May Affect Wireless Capsule (WC) Endoscopy 98
Emerging biologics in the treatment of inflammatory bowel disease: what is around the corner? 97
Acute Severe Colitis: Infliximab and/or Cyclosporine? 96
Anti-TNF's for postoperative recurrence in Crohn's disease: the if's and how's. 95
Adalimumab in ulcerative colitis: hypes and hopes 94
Heat shock protein 47 is a new candidate molecule as anti-fibrotic treatment of Crohn's disease: authors' reply 94
Familial aggregation in inflammatory bowel disease: Is it genes or environment? 93
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 91
Infliximab Inhibits Mucosal Pathological Angiogenesis in Crohn's Disease 90
Anti-TNF Therapy in Inflammatory Bowel Diseases 89
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 87
A prospective comparison between 1.5T magnetic resonance and 3T magnetic resonance in ileo-colonic Crohn’s disease: a single center experience. 86
Adalimumab in Crohn's Disease: Tips and Tricks After 5 Years of Clinical Experience 85
A prospective comparison between CT enterography and MR enterography (MRE) in ileo-colonic Crohn’s disease: a single-center experience. 83
Postoperative recurrence of Crohn's disease and videocapsule endoscopy: it is necessary to leave no stone unturned. 81
Biological Therapy for Ulcerative Colitis: what is after Anti-TNF. 78
Review article: anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseases. 77
Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease 77
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study. 71
Videocapsule Endoscopy in Portal Hypertension 71
Influenza A (H1N1)v infection in patients with inflammatory bowel disease: a case series. 70
Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease. 69
Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease. 69
Safety of a (H1N1)V Vaccine in patients with inflammatory bowel disease treated with immunomodulators and biologicals 68
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study 64
Risk of postoperative recurrence and postoperative management of Crohn's disease. 63
The bacterial sensor Triggering Receptor Expressed on Myeloid cells 2 (TREM-2) is a crucial pathogenic mediator in inflammatory bowel disease (IBD) 62
The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab. 56
New drug delivery systems in inflammatory bowel disease: MMX and taylored delivery to the gut. 56
MRI in Crohn's disease-current and future clinical applications. 53
Mucosal healing in Ulcerative Colitis: Where do we Stand? 51
Use of biosimilars in inflammatory bowel disease: Statements of the Italian Group for Inflammatory Bowel Disease. 51
Review article: Causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-α therapy. 45
null 37
null 31
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD) 31
null 27
Totale 3.267
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.699
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021142 0 0 0 0 0 34 1 3 1 41 33 29
2021/2022246 1 20 3 12 5 1 8 8 1 36 54 97
2022/2023797 73 71 42 102 50 80 15 34 308 10 8 4
2023/2024189 14 29 7 48 20 30 3 13 2 16 0 7
2024/2025729 5 6 25 49 26 28 24 135 204 40 51 136
2025/2026609 54 158 125 84 158 30 0 0 0 0 0 0
Totale 3.267